Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.

NCT00325416 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

177

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: melphalan
DRUG: topotecan (TPT)
PROCEDURE: Autologous Stem Cell Rescue

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]